This test is most useful if any of these apply to you.
This hormone decides whether your kidneys hold onto water or let it go. When it drops too low, or your kidneys stop responding to it, you can pass several liters of dilute urine a day and stay thirsty no matter how much you drink. When it runs too high, water builds up and the sodium in your blood falls, which can bring on confusion, nausea, and in severe cases seizures.
Most people never think about it until something goes wrong with thirst, urination, or a sodium result that makes no sense. A single blood level of this hormone is harder to pin down than almost any other. That matters before you order it.
Antidiuretic hormone, also called ADH or arginine vasopressin (AVP), is made by nerve cells in the hypothalamus. The hypothalamus is a control center deep in the brain. ADH is released into the blood from the posterior pituitary gland just beneath it, the same gland that releases oxytocin.
Its main job runs in the kidney. When you are low on water, the hormone signals the kidney's final drainage tubes to pull water back into the blood instead of losing it as urine. It does this by moving tiny water channels into place. Those channels are called aquaporins. That is why more ADH means less urine, and less ADH means more.
At high levels it also tightens blood vessels, which is where the name vasopressin came from. At the everyday amounts your body actually runs, that blood-pressure effect is small, and the water job is what matters.
The classic disorder of too much ADH effect is the syndrome of inappropriate antidiuretic hormone secretion, or SIADH. Here ADH keeps telling your kidneys to hold water even when your blood is already too dilute, so sodium falls. SIADH is the most common cause of low sodium in hospitalized patients, and the usual first steps of fluid restriction and isotonic saline fail to raise sodium in more than half of treatment episodes.
SIADH was first described in 1957 in two people with lung cancer. Their water balance behaved as if ADH were being released at the wrong time; later work showed that some tumors can make AVP themselves. Up to about 15 percent of people with small-cell lung cancer develop SIADH. Medications are another major source: antidepressants, antiseizure drugs, and antipsychotics together account for about two thirds of drug-triggered cases, and brain and lung conditions can set it off too.
Too little of this hormone, or kidneys that ignore it, produces the opposite picture: a flood of dilute urine and constant thirst. This is diabetes insipidus. The shared word is misleading: blood sugar is not the problem. It is uncommon, affecting roughly 1 in 25,000 people, which is part of why it is often missed.
There are two main forms. In the central form the brain does not make enough of the hormone, often after head trauma, pituitary surgery, or a tumor. In the kidney-resistant form the hormone is present but the kidney cannot respond. Newer papers call these AVP deficiency and AVP resistance. Long-term lithium causes a kidney concentrating defect in roughly 40 to 55 percent of users; the full syndrome with heavy urination is less common.
A high level is not automatically bad, and a low one is not automatically good. In SIADH the hormone is high and doing harm by holding water. In the kidney-resistant form of diabetes insipidus the hormone is also high, but the trouble is the kidney ignoring it, and the person is losing water fast. The number alone cannot tell these apart. This is a pattern marker, not a simple good-number/bad-number test, and it only makes sense read next to your blood sodium and how concentrated your urine is.
The long-term outcome research almost never measures ADH directly. It measures copeptin, a fragment released from the same molecule in equal amounts and far easier to detect. Treat the findings below as being about that stand-in, not about a direct ADH level, and as associations rather than proof of cause.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| About 16,000 adults across three European groups | Higher stand-in level vs lower | More likely to develop chronic kidney disease and to lose kidney function faster |
| About 5,300 older adults | Higher stand-in level vs lower | Higher chance of developing heart failure over follow-up |
| About 2,000 adults without diabetes | Higher stand-in level vs lower | More likely to develop diabetes and gain weight around the middle |
Sources: El Boustany et al. 2018 (kidney disease); Schill et al. 2021 (heart failure); Enhörning et al. 2013, Malmö Diet and Cancer cohort (diabetes).
What this means for you: a higher habitual vasopressin signal often travels with low water intake and concentrated urine. Drinking more water lowers copeptin in short human studies. Whether that lowers your actual risk has not been proven, so read this as a research clue, not a diagnosis you can act on from one draw.
Most direct tests measure ADH in frozen plasma from a venous blood draw. Usual blood levels are so low that many assays are working near their lower limit. The hormone is unstable once drawn and breaks down within minutes, with a half-life of roughly 24 minutes, and much of it sticks to platelets rather than floating free.
That fragility is why copeptin exists. Because it comes off the same precursor in equal amounts but survives in the tube, most modern testing leans on it instead of the raw hormone. Know this before you interpret a direct result: the assay is working near its own limits, so a single number carries real uncertainty.
Because the level swings with hydration, time of day, stress, and sample handling, a single random draw rarely settles anything. The disorders behind an abnormal result also come in several patterns that only show up when you watch the hormone response under controlled conditions.
For a suspected water-balance disorder, a supervised water-deprivation test or a stimulation test with copeptin does far more than repeated casual sampling. The point is to see the response, not to chase one isolated hormone value.
A lone ADH number is close to meaningless without company. Pair it with your blood sodium, your blood and urine concentration, and a urine sodium. Rule out the common mimics of heavy urination: check glucose for diabetes mellitus, calcium for high calcium, potassium for low potassium, and kidney function, since all of these can drive dilute urine or shift the hormone.
If the picture points to low sodium, the main split is SIADH versus renal salt wasting. In renal salt wasting, the kidney is losing salt and water. The treatments point in opposite directions: one calls for fluid restriction, the other for salt and fluid. Getting this wrong is a documented cause of harm, so this is the point to bring in an endocrinologist or nephrologist and, where needed, a formal copeptin-based or water-deprivation test rather than acting on the raw value.
Evidence-backed interventions that affect your ADH level
Antidiuretic Hormone is best interpreted alongside these tests.